Connect with colleagues from around the world when you attend
the World Congress of Gastroenterology at ACG2017!

Exhibitor Theaters

At the World Congress of Gastroenterology at ACG2017 there are a number of opportunities to network with your peers and have some fun as well! Learn what ACG and the WGO are doing for you, see training programs compete in GI Jeopardy, go on an ACG Auxiliary tour, and attend one of the many company-sponsored events.

Open to all WCOG at ACG2017 attendees, Exhibitor Theaters may be provided by an Exhibitor or the ACG or WGO. These presentations provide additional educational opportunities for attendees. No CME is provided for Theater presentations.


Considerations in the Management of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain
Sunday, October 15, 2017 | 5:30 pm – 6:30 pm | Exhibit Hall

Speaker: Brooks D. Cash, MD, FACG

Sponsored by Purdue Pharma, L.P. and Shionogi Inc.


Treatment Options for IBS-D, IBS-C and CIC:  A Clinical Review
Monday, October 16, 2017 | 10:30 am – 11:30 am | Exhibit Hall

Speaker: Brooks D. Cash, MD, FACG

Sponsored by Allergan USA, Inc.


Biosimilars in Practice: Important Concepts to Know
Monday, October 16, 2017 | 12:45 pm – 1:20 pm | Exhibit Hall

Speaker: Garrett Lawlor, MD

With biosimilars now a reality, this program will present key concepts on the unique biosimilar development pathway and review extrapolation and interchangeability considerations. A case study will also take the audience through FDA considerations of extrapolation for an approved biosimilar.

Sponsored by Pfizer


IBS-D: Diagnosis and Management of Abdominal Pain and Diarrhea
Monday, October 16, 2017 | 1:40 pm – 2:15 pm | Exhibit Hall

Speaker: Mark Pimentel, MD, FACG, FRCP

Join Dr. Mark Pimentel for an expert overview of IBS-D at a presentation entitled “IBS-D: Diagnosis and Management of Abdominal Pain and Diarrhea”. The presentation will include a discussion of the common and most bothersome symptoms of IBS-D, appropriate diagnosis, general goals for therapy, and FDA approved treatment options.

Sponsored by Salix Pharmaceuticals


Expanding Options in PBC
Monday, October 16, 2017 | 3:30 pm – 4:30 pm | Exhibit Hall

Speaker: Mitchell L. Shiffman, MD, FACG

Join us for an informative presentation about the latest advances in primary biliary cholangitis (PBC). Learn about an approved treatment for patients with an inadequate response to ursodeoxycholic acid (UDCA).

This program is provided by Intercept Pharmaceuticals, Inc.


Changing Expectations: A Review of Sofosbuvir-based Regimens.
Tuesday, October 17, 2017 | 10:45 am – 11:45 am | Exhibit Hall

Speaker: Mitchell L. Shiffman, MD, FACG

Sponsored by Gilead


Advanced Polypectomy: Tools & Techniques
Tuesday, October 17, 2017 | 1:00 pm – 1:35 pm | Exhibit Hall

Speaker: David L. Diehl, MD

Please join us for a discussion around tips, techniques and the latest tools to manage flat polyps.

This program is sponsored by US Endoscopy


Movantik: Opioid-Induced Constipation: The Science, Patient Burden, and a Prescription Treatment Approach
Tuesday, October 17, 2017 | 1:50 pm – 2:30 pm | Exhibit Hall

Speaker: Brooks D. Cash, MD, FACG

Sponsored by AstraZeneca